New Cash Moves NorthSea Up In NASH

€36m Raised By Dutch Biotech

 
• By Kevin Grogan

With two new US investors on board, NST is financed to complete a Phase IIb trial of icosabutate in non-alcoholic steatohepatitis.

Euros
Cash boost for Dutch biotech Northsea • Source: Shutterstock

More from Financing

More from Business